Thu, Aug 21, 2014, 7:22 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Opko Health, Inc. Message Board

  • burnaka@sbcglobal.net burnaka Apr 25, 2013 2:25 PM Flag

    Ice why would the pbth share holders be whining, I have looked over PBTH this is what I see

    They absolutely needed a partner or they were in license only mode for pennies on the dollar. They have been somewhat dragging their feet because even if phase 3 was finished, then what??? A product and no way to market even one prescription. They would also be out of cash at that time. Merck is using the same technology with drugs, so that is a REAL viable partner. With the other two Israeli companies we own, and the fact this will be a spinable division, and we can market their products through Our Lab and other avenues, one would think they would be thrilled. Nope, baseless law suit. I like the GO Shop clause, a wrench in the ambulance chasers law suit. I would question if they had sought a license partner, but that short changes share holders in the long run. It can be argued that OPK grossly over paid when compared to the two other already in progress phase 3 products, pbth has not even started a phase three, and is bleeding cash. Of course if I did the deal there would be a real law suit, I would have offered 100M, about 2 bucks a share.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I suppose some of them just don't understand the deal, but there also may be vocal ones who are trying to create some good old fashioned FUD (shorts or wanting to shake out shares to accumulate). Might even be one or two working for one of the ambulance chasers. :-)

      • 2 Replies to icemandios
      • Yep, 1,000,000 PBTH short position trapped. There may be whining, maybe a shake the tree SA article. i bought a litlle PBTH figured it was a discount way to get more OPK.

        Sentiment: Strong Buy

      • burnaka@sbcglobal.net burnaka Apr 25, 2013 2:49 PM Flag

        My only thought was with the smallish 40+ million shares, pbth holders expected a major spike to 12-15 after phase 3 was done. Could of happened, but by then the company would be broke, and still need a partner, and it is a year and a half off too. Unless Merck steps up, this is their best shot. Also if Merck steps up and pays say, 10.00, that is it, they are out, no more upside. Here with this deal 4 phase 3 projects, plus diagnostics, opk will get way beyond the Merck deal, a win win for opk and pbth.
        but they get our 3 phase 3 for free. So who really is the winner? They are.

 
OPK
8.82-0.06(-0.68%)Aug 21 4:01 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.